| 中文名称 | 布瓦西坦 |
|---|---|
| 中文别名 | 布瓦西坦;(αS,4R)-α-乙基-2-氧代-4-丙基-1-吡咯烷乙酰胺;1.2-丙二醇(丙二醇);布立西坦;布瓦西坦[仅供出口];布瓦西坦-Brivaracetam;氰霜唑;湖北扬信现货供应布瓦西坦杂质ABCDE |
| 英文名称 | Brivaracetam |
| 英文别名 | 1-Pyrrolidineacetamide,a-ethyl-2-oxo-4-propyl-, (aS,4R)-;Brivaracetam;(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide;Rikelta;UCB 34714;UCB-34714;(alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide;BRIVARACETAM [ORANGE BOOK];BRIVARACETAM (MART.);SCHEMBL122081;BRIVARACETAM [MART.];Brivaracetam [USAN:INN];1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-; (alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide; Brivaracetam; Briviact; UCB 34714;(2S)-2-((4R)-2-OXO-4-PROPYLTETRAHYDRO-1H-PYRROL-1-YL) BUTANAMIDE;AKOS027324306;Briviact;GTPL9041;DB05541;AC-29289;D08879;1-PYRROLIDINEACETAMIDE, .ALPHA.-ETHYL-2-OXO-4-PROPYL (.ALPHA.S,4R)-;NS00068020;357336-20-0;AS-35277;UNII-U863JGG2IA;AE5 - Anti-epileptic drugs 5;BDBM50422531;NCGC00390779-02;CHEMBL607400;BB161996;1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-;BRIVARACETAM [JAN];(2S)-2-((4R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide;BRIVARACETAM [MI];BRIVARACETAM [INN];brivaracetamum;2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide;MSYKRHVOOPPJKU-BDAKNGLRSA-N;CS-3418;(S)-2-((R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide;CCG-266666;BRIVARACETAM [USAN];MFCD25976668;Briviact (TN);EX-A2748;U863JGG2IA;CHEBI:133013;DTXSID00905081;N03AX23;Q408099;(2S)-2-((4R)-2-oxo-4-n-propyl-1-pyrrolidinyl)butanamide;1-PYRROLIDINEACETAMIDE, alpha-ETHYL-2-OXO-4-PROPYL (alphaS,4R)-;HY-14449;BRIVARACETAM [WHO-DD];Brivaracetam (JAN/USAN/INN);compound 83alpha;UCB34714;(R)-Atomoxetine;(2S)-2-[(4R)-2-oxidanylidene-4-propyl-pyrrolidin-1-yl]butanamide;BRD-K00634421-001-01-0;Brivaracetam?;GLXC-27574 |
| CAS No. | 357336-20-0 |
| 分子式 | C11H20N2O2 |
| 分子量 | 212.29 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学